EdenTree Amity Global Equity Inc Fd for Charities

Ranked 46 out of 101 in - Global Equity Income over 12 months
All calculations are in GBP unless stated

Managed by

David Osfield

David Osfield joined EdenTree in July 2016 as joint fund manager on the Amity International fund after beginning his career at Alliance Trust in 2002. During his time there David largely focused on Asian equities, although has also covered pan-European and Global equities. His investment philosophy focuses on long-term, bottom up investing and is passionate about sustainable investing. David has a 1st class BA (Hons) in Business Finance from Durham University and is a CFA Charterholder.

Ketan Patel

Ketan Patel currently works at EdenTree Investment Management. He began his career on the equity derivatives trading desk at JP Morgan, before moving to Insight Investment as a global healthcare analyst. He has been a CFA Charterholder since 2009, holds an undergraduate degree in History & Geography and post-graduate degrees in both Geography and Economics from the University of London.


The Fund’s primary objective is to provide an above average income yield with a secondary aim of achieving capital appreciation over the longer term. The Fund seeks to primarily invest in a diversified portfolio of higher yielding equities of UK and international companies which make a positive contribution to society and the environment through sustainable and socially responsible practices.

Showing fund performance in United Kingdom View performance globally


Global Equity Income over : 31/03/2018 - 31/03/2019

Total Return

Quarterly Performance

to 31/03/2019 Annual Q1 Q2 Q3 Q4
2019 7.1%
2018 -3.2% -4.6% 5.1% 5.9% -8.8%
2017 15.3% 7.2% 1.7% 3.1% 2.6%
2016 18.3% -0.5% 2.0% 8.8% 7.2%
2015 1.3% 5.7% -3.9% -7.4% 7.7%
2014 8.9% -0.6% 2.7% 3.2% 3.3%
2013 15.1% 14.6% -3.7% 1.2% 3.1%
2012 9.1% 4.3% -4.6% 5.3% 4.2%
2011 -15.6% 2.5%

Month by Month Performance

Returns Vs Risk

Asset Allocation



Top 10 Holdings

Stock Size
Cisco Systems Inc ORD 4.26%
Microsoft Corp ORD 3.96%
Bioventix PLC ORD 3.96%
Pfizer Inc ORD 3.33%
Taiwan Semiconductor Manufacturing Co Ltd DR 2.64%
ASR Nederland NV ORD 2.60%
Deere & Co ORD 2.41%
GlaxoSmithKline PLC ORD 2.26%
Novartis AG ORD 2.18%
Merck & Co Inc ORD 2.15%

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date04/04/2011
  • Share Class size13Mn
  • Base currencyGBP
  • ISIN GB00B45M5W55

Purchase Info

  • Min. initial investment1,000
  • Min. regular additional investment0


  • Annual management0.75%
  • Initial investment0.00%

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).